American Substance Abuse Professionals

01/27/2026

🚨Ma*****na Rescheduling Executive Order Explained🚨

The federal government has directed DOJ to complete the process of moving ma*****na from Schedule I to Schedule III under the Controlled Substances Act—but what does this really mean for employers and DOT SAPs?

Key takeaway: Nothing has changed for DOT-regulated drug and alcohol testing programs.

✔️ Ma*****na remains prohibited for safety-sensitive employees
✔️ DOT testing regulations remain fully in effect
✔️ Return-to-Duty requirements still apply

Safety advocates continue to raise concerns about what happens after rescheduling—especially without impairment standards or regulatory carve-outs for safety-sensitive positions.

🔗 Read the full blog for what employers should know, what hasn’t changed, and how to stay compliant: [https://go2asap.com/dot-resource-articles-education/ma*****na-rescheduling-executive-order-explained/]

*****naRescheduling

01/22/2026

How DOT Random Testing Works?

Each year, the U.S. Department of Transportation (DOT) reviews employer MIS data to determine random drug and alcohol testing rates—a critical safeguard for safety-sensitive positions.

🚨 Key 2026 Update:
• FRA Mechanical safety-sensitive positions
• Random alcohol testing rate reduced from 25% to 10%
• All other DOT agency rates remain unchanged

For HR and Safety Managers, understanding how DOT random testing works, what’s required for compliance, and what happens after a positive test is essential to avoiding violations and protecting public safety.

Read the breakdown, 2026 testing rates, employer responsibilities, and RTD requirements:
🔗 [https://go2asap.com/dot-resource-articles-education/how-dot-random-testing-works/]

Learn how DOT random testing works, annual rates, what changed for 2026, and why compliance is critical for safety-sensitive employers.

01/02/2026

Happy New Year! Here’s to safety, growth, and new opportunities in 2026.

#2026

12/22/2025

Executive Order to drive completion of rescheduling of Ma*****na but NO immediate changes to DOT regulated testing

On December 18, 2025, the President of the United States issued an Executive Order directing the Department of Justice to complete the rescheduling process of ma*****na from a Schedule I to a Schedule III drug of the Controlled Substances Act (CSA).

We have had inquiries about what impact this Executive Order will have on the Department of Transportation’s longstanding regulation about the use of ma*****na by safety‐sensitive transportation employees – pilots, school bus drivers, truck drivers, train engineers, subway operators, aircraft maintenance personnel, transit fire‐armed security personnel, ship captains, and pipeline emergency response personnel, among others.

First – ma*****na is still a Schedule I drug under the CSA until any rescheduling is complete. It remains unacceptable for any safety‐sensitive employee subject to drug testing under the Department of Transportation’s drug testing regulations to use ma*****na.

Second – until the rescheduling process is complete, the Department of Transportation’s drug testing process and regulations will not change. Transportation employees in safety-sensitive positions will still be subject to testing for ma*****na. Furthermore, the Department’s guidance on medical and recreational ma*****na and CBD are still in effect.

Laboratories, Medical Review Officers and Substance Abuse Professionals must continue to follow 49 CFR Part 40. There are no changes to your roles and responsibilities as they relate to ma*****na.

We will continue to monitor the rescheduling process and update the transportation industry as appropriate.

We want to assure the traveling public that our transportation system is the safest it can possibly be.


Source: U.S. Department of Transportation, Office of Drug & Alcohol Policy & Compliance. Official Notice regarding ma*****na rescheduling and continued enforcement of 49 CFR Part 40, issued December 19, 2025.


*****naPolicy

12/17/2025

ASAP hopes your holidays are relaxing and filled with meaningful moments. Your support means a lot, and we truly appreciate being part of your year!

We’re wishing you growth, new opportunities, and continued success as we move into the year ahead!

12/16/2025

🚨 Ma*****na Rescheduling & Public Safety: What Employers Need to Know

The federal government is considering rescheduling ma*****na, and this could have major implications for safety-sensitive employees in transportation and other critical industries.
Join the National Drug & Alcohol Screening Association (NDASA) for a live discussion with Congressman Pete Sessions (R-TX), Congressman Andy Harris (R-MD), and industry experts to explore:

• How rescheduling affects drug-testing authority
• Implications for pilots, school bus drivers, truck drivers, and other safety-sensitive workers
• Differences between Schedule II vs. Schedule III
• How employers can protect public safety

📅 Date: December 16, 2025
⏰ Time: 4:00 PM EST
🎥 Live stream (open to the public)

This conversation is essential for DOT-regulated employers, HR leaders, SAPs, DERs, and anyone responsible for workplace safety.

🔗 Register here: https://ndasa.com/2025/12/09/national-conversation-on-ma*****na/

Read More Here: https://go2asap.com/dot-resource-articles-education/ma*****na-rescheduling/

*****naRescheduling

The National Drug & Alcohol Screening Association (NDASA) is hosting a national conversation to discuss the public safety implications surrounding the

10/21/2025

🚨Record-Breaking Drug Seizure by U.S. Coast Guard🚨

The U.S. Coast Guard offloaded over 76,000 lbs of illegal narcotics in South Florida – the largest in its history, valued at $473 million. This operation prevented roughly 23 million lethal doses from reaching communities and dismantled key trafficking networks.

A powerful reminder of the impact of law enforcement and safety programs in protecting our workplaces and communities.

10/13/2025

National Drug-Free Work Week (Oct 13–17) is a reminder that recovery-friendly workplaces benefit everyone.

✅ Clear policies
✅ Supervisor & employee training
✅ EAP + DOT SAP programs tailored to your culture
✅ Drug & alcohol testing as a deterrent

In 2020, 468,000 full-time workers were in recovery—up 44% from the year before (Safety+Health Magazine).
Let’s build workplaces where employees feel safe to ask for help, return stronger, and thrive.

09/30/2025

🚨 Fentanyl use in the workplace is on the rise🚨

According to the 2025 Quest Diagnostics Drug Testing Index, fentanyl positivity in random workplace drug tests is more than seven times higher than in pre-employment screenings
(1.13% vs. 0.14%).

Even more concerning:
👉 60% of fentanyl-positive specimens
also contained other drugs
👉 Co-positivity with ma*****na
doubled since 2020 (10% ➝ 22%)
👉 Amphetamine co-positivity
also increased (11% ➝ 16%)

These findings underscore the limitations of relying on pre-employment testing alone. Ongoing random, post-accident, and for-cause testing remains critical to safeguarding workplace safety.

09/23/2025

🚨ASAP is Attending SAPAA- Don’t Miss Us!🚨

📢Join us for our session:
Breaking Down the Return-to-Duty (RTD) Process with the Experts!

📍Meet the ASAP Team at Booth 208!
Let’s talk RTD strategies, recovery-friendly workplaces, and how to support second chances the right way.

09/12/2025

🌟 Exciting news from ASAP! 🌟

We’re proud to announce that Tara Sauers has been elected to the SAPAA Board of Directors.

09/02/2025